Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

541 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
Baud O, Maury L, Lebail F, Ramful D, El Moussawi F, Nicaise C, Zupan-Simunek V, Coursol A, Beuchée A, Bolot P, Andrini P, Mohamed D, Alberti C; PREMILOC trial study group. Baud O, et al. Among authors: alberti c. Lancet. 2016 Apr 30;387(10030):1827-36. doi: 10.1016/S0140-6736(16)00202-6. Epub 2016 Feb 23. Lancet. 2016. PMID: 26916176 Clinical Trial.
[Glucocorticoide therapy in premature infants: French practices in 2006].
Autret-Leca E, Bauer S, Alberti C, Jonville-Béra AP, Aujard Y, Bensouda-Grimaldi L, Baud O. Autret-Leca E, et al. Among authors: alberti c. Arch Pediatr. 2009 Jul;16(7):999-1004. doi: 10.1016/j.arcped.2009.03.013. Epub 2009 May 1. Arch Pediatr. 2009. PMID: 19410441 French.
Is melatonin ready to be used in preterm infants as a neuroprotectant?
Biran V, Phan Duy A, Decobert F, Bednarek N, Alberti C, Baud O. Biran V, et al. Among authors: alberti c. Dev Med Child Neurol. 2014 Aug;56(8):717-23. doi: 10.1111/dmcn.12415. Epub 2014 Feb 27. Dev Med Child Neurol. 2014. PMID: 24575840 Free article. Review.
VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial.
Courbebaisse M, Alberti C, Colas S, Prié D, Souberbielle JC, Treluyer JM, Thervet E. Courbebaisse M, et al. Among authors: alberti c. Trials. 2014 Nov 6;15:430. doi: 10.1186/1745-6215-15-430. Trials. 2014. PMID: 25376735 Free PMC article. Clinical Trial.
541 results